News » Press Room » Press Archives

Press Archives

George Kim, MD, director of the Gastrointestinal Cancers Program at the GW Cancer Center
March 19, 2019

The GW Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.

Read More
March 15, 2019

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.

Read More
February 26, 2019

A group of student and faculty researchers from the GW School of Medicine and Health Sciences published outcome of establishing Rheumatology Interest Group in the International Journal of Rheumatology.

Read More
Marcia Firmani, PhD, MSPH, chair OF the Department of Biomedical Laboratory Sciences at the GW School of Medicine and Health Sciences
February 25, 2019

Marcia Firmani, PhD, MSPH, was tapped to chair the Department of Biomedical Laboratory Sciences at the GW School of Medicine and Health Sciences. 

Read More
January 30, 2019

Researchers from GW, FDA, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute.

Read More
January 28, 2019

Rohan Fernandes, PhD, received more than $1.6 million from the National Institutes of Health to investigate nanoimmunotherapies for cancer

Read More
Vishal A. Patel, MD, will serve as the director of the recently established Cutaneous Oncology Program at the GW Cancer Center.
January 17, 2019

The GW Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program.

Read More
January 15, 2019

For the first time, researchers at the GW School of Medicine and Health Sciences have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer. 

Read More